"10.1371_journal.pone.0052976","plos one","2012-12-31T00:00:00Z","Juan Martin Caballero; Ana Garzón; Leticia González-Cintado; Wioleta Kowalczyk; Ignacio Jimenez Torres; Gloria Calderita; Margarita Rodriguez; Virgínia Gondar; Juan Jose Bernal; Carlos Ardavín; David Andreu; Thomas Zürcher; Cayetano von Kobbe","Laboratory Animal Unit, Barcelona Biomedical Research Park, Barcelona, Spain; Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain; Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Barcelona, Spain","Conceived and designed the experiments: CvK TZ JMC CA. Performed the experiments: JMC AG LGC GC MR VG. Analyzed the data: JMC AG CvK TZ DA CA. Contributed reagents/materials/analysis tools: JJB DA IJT WK. Wrote the paper: CvK.","AG, IJT, GC, MR, VG, JJB, TZ and CvK were employed by Chimera Pharma S.L.U. during the course of this project. Currently Chimera Pharma is under judicial liquidation after a meeting of creditorś period of time. None of the authors belongs to Chimera anymore. The VLP-E7 and VLP-E7-B constructs described in this paper are now propietary of VLP The Vaccineś Company S.L. (VLP Bio) and protected under PCT WO 2011/054996. The new owners of the intellectual property rights agree with the publication of these data. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Juan Martin Caballero","JMC",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
